Evotec SE EVO
NASDAQ EVO
$1.67 +0.05 (+3.09%)
At close: Sep 17, 2026 · 4:00 PM EDT

Evotec SE (EVO) Cash from Financing Activities (2009 - 2026)

Evotec SE's (EVO) quarterly Cash from Financing Activities came in at -$22.3 million in Q1 2026, down 159.97% year-over-year from $37.3 million in Q1 2025, and down 192.61% quarter-over-quarter from $24.1 million in Q4 2025.

Analysis

Evotec SE (EVO) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Evotec SE has disclosed Cash from Financing Activities across 9 years of filings, most recently posting -$22.3 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 159.97% year-over-year to -$22.3 million; the TTM figure through Mar 2026 stood at -$29.0 million (up 77.69% YoY), while the FY2025 annual figure was -$42.5 million, up 75.67% from the prior year.
  • Cash from Financing Activities came in at -$22.3 million for Q1 2026 at Evotec SE, down from $24.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $37.3 million in Q1 2025 to a low of -$128.2 million in Q2 2024.
  • Average Cash from Financing Activities over 5 years is -$11.9 million, with a median of -$7.1 million recorded in 2022.
  • Year-over-year, Cash from Financing Activities plunged 1780.81% in 2024 and surged 684.31% in 2025.
  • Over 5 years, Cash from Financing Activities stood at -$7.8 million in 2022, then surged by 416.81% to $24.9 million in 2023, then tumbled by 226.06% to -$31.3 million in 2024, then soared by 177.01% to $24.1 million in 2025, then sank by 192.61% to -$22.3 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$22.3 million in Q1 2026, $24.1 million in Q4 2025, and -$14.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -214.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -288.34 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -8.12 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -164.66 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 16.49 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 33,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 248,151.59
10 VivoSim Labs 1.37 Mn 1.37 Mn - -118,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -22.35 Mn
Dec 31, 2025 24.13 Mn
Sep 30, 2025 -14.19 Mn
Jun 30, 2025 -16.64 Mn
Mar 31, 2025 37.27 Mn
Dec 31, 2024 -31.34 Mn
Sep 30, 2024 -7.89 Mn
Jun 30, 2024 -128.19 Mn
Mar 31, 2024 -6.38 Mn
Dec 31, 2023 24.86 Mn
Jun 30, 2023 7.63 Mn
Mar 31, 2023 3.73 Mn
Dec 31, 2022 -7.85 Mn
Sep 30, 2022 -4.69 Mn
Jun 30, 2022 -43.24 Mn
Mar 31, 2022 -5.92 Mn
Dec 31, 2021 441.41 Mn
Sep 30, 2021 -6.26 Mn
Jun 30, 2021 -6.59 Mn
Mar 31, 2021 21.63 Mn